Jundishapur Journal of Natural Pharmaceutical Products

Published by: Kowsar

The Effect of Date Seed (Phoenix dactylifera) Extract on Paraoxonase and Arylesterase Activities in Hypercholesterolemic Rats

Mohammad Reza Takaeidi 1 , Alireza Jahangiri 2 , Mohammad Javad Khodayar 3 , * , Amir Siahpoosh 1 , 4 , Hamid Yaghooti 5 , Saeid Rezaei 6 , Maryam Salecheh 1 and Zahra Mansourzadeh 1
Authors Information
1 Medicinal Plants and Natural Products Research Center, School of Pharmacy, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, IR Iran
2 Department of Medicinal Chemistry and Nanotechnology center, School of Pharmacy, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, IR Iran
3 Department of Pharmacology and Toxicology Research Center, School of Pharmacy, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, IR Iran
4 Department of Pharmacognosy, School of Pharmacy, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, IR Iran
5 Department of Medical Laboratory Sciences, School of Allied Medical Sciences Ahvaz Jundishapur University of Medical Sciences, Ahvaz, IR Iran
6 Department of Pharmaceutics, School of Pharmacy, Zanjan University of Medical Sciences, Zanjan, IR Iran
Article information
  • Jundishapur Journal of Natural Pharmaceutical Products: February 01, 2014, 9 (1); 30-34
  • Published Online: February 10, 2014
  • Article Type: Research Article
  • Received: January 20, 2013
  • Revised: August 11, 2013
  • Accepted: October 8, 2013
  • DOI: 10.17795/jjnpp-10368

To Cite: Takaeidi M R, Jahangiri A, Khodayar M J, Siahpoosh A, Yaghooti H, et al. The Effect of Date Seed (Phoenix dactylifera) Extract on Paraoxonase and Arylesterase Activities in Hypercholesterolemic Rats, Jundishapur J Nat Pharm Prod. 2014 ; 9(1):30-34. doi: 10.17795/jjnpp-10368.

Copyright © 2014, School of Pharmacy, Ahvaz Jundishapur University of Medical Sciences. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Materials and Methods
4. Results
5. Discussion
  • 1. Costa LG, Giordano G, Furlong CE. Pharmacological and dietary modulators of paraoxonase 1 (PON1) activity and expression: the hunt goes on. Biochem Pharmacol. 2011; 81(3): 337-44[DOI][PubMed]
  • 2. Costa LG, Richter RJ, Li WF, Cole T, Guizzetti M, Furlong CE. Paraoxonase (PON 1) as a biomarker of susceptibility for organophosphate toxicity. Biomarkers. 2003; 8(1): 1-12[DOI][PubMed]
  • 3. Aviram M. Introduction to paraoxonases. J Lipids. 2012; 2012: 1-3[DOI][PubMed]
  • 4. Androutsopoulos VP, Kanavouras K, Tsatsakis AM. Role of paraoxonase 1 (PON1) in organophosphate metabolism: implications in neurodegenerative diseases. Toxicol Appl Pharmacol. 2011; 256(3): 418-24[DOI][PubMed]
  • 5. Camps J, Marsillach J, Joven J. The paraoxonases: role in human diseases and methodological difficulties in measurement. Crit Rev Clin Lab Sci. 2009; 46(2): 83-106[DOI][PubMed]
  • 6. Camps J, Marsillach J, Joven J. Pharmacological and lifestyle factors modulating serum paraoxonase-1 activity. Mini Rev Med Chem. 2009; 9(8): 911-20[PubMed]
  • 7. Costa LG, Vitalone A, Cole TB, Furlong CE. Modulation of paraoxonase (PON1) activity. Biochem Pharmacol. 2005; 69(4): 541-50[DOI][PubMed]
  • 8. Tomas M, Senti M, Garcia-Faria F, Vila J, Torrents A, Covas M, et al. Effect of simvastatin therapy on paraoxonase activity and related lipoproteins in familial hypercholesterolemic patients. Arterioscler Thromb Vasc Biol. 2000; 20(9): 2113-9
  • 9. van Wijk J, Coll B, Cabezas MC, Koning E, Camps J, Mackness B, et al. Rosiglitazone modulates fasting and post-prandial paraoxonase 1 activity in type 2 diabetic patients. Clin Exp Pharmacol Physiol. 2006; 33(12): 1134-7[DOI][PubMed]
  • 10. Wojcicka G, Jamroz-Wisniewska A, Marciniak A, Lowicka E, Beltowski J. The differentiating effect of glimepiride and glibenclamide on paraoxonase 1 and platelet-activating factor acetylohydrolase activity. Life Sci. 2010; 87(3-4): 126-32[DOI][PubMed]
  • 11. Mackness B, Mackness MI, Arrol S, Turkie W, Julier K, Abuasha B, et al. Serum paraoxonase (PON1) 55 and 192 polymorphism and paraoxonase activity and concentration in non-insulin dependent diabetes mellitus. Atheroscler. 1998; 139(2): 341-9
  • 12. Kiyici A, Okudan N, Gokbel H, Belviranli M. The effect of grape seed extracts on serum paraoxonase activities in streptozotocin-induced diabetic rats. J Med Food. 2010; 13(3): 725-8[DOI][PubMed]
  • 13. Koren-Gluzer M, Aviram M, Meilin E, Hayek T. The antioxidant HDL-associated paraoxonase-1 (PON1) attenuates diabetes development and stimulates beta-cell insulin release. Atherosclerosis. 2011; 219(2): 510-8[DOI][PubMed]
  • 14. Baliga MS, Baliga BRV, Kandathil SM, Bhat HP, Vayalil PK. A review of the chemistry and pharmacology of the date fruits (Phoenix dactylifera L.). Food Res Int. 2011; 44(7): 1812-22
  • 15. Al-Farsi MA, Lee CY. Nutritional and functional properties of dates: a review. Crit Rev Food Sci Nutr. 2008; 48(10): 877-87[DOI][PubMed]
  • 16. Vayalil PK. Date fruits (Phoenix dactylifera Linn): an emerging medicinal food. Crit Rev Food Sci Nutr. 2012; 52(3): 249-71[DOI][PubMed]
  • 17. Soong YY, Barlow PJ. Antioxidant activity and phenolic content of selected fruit seeds. Food Chem. 2004; 88(3): 411-7
  • 18. Al-Farsi MA, Lee CY. Optimization of phenolics and dietary fibre extraction from date seeds. Food Chem. 2008; 108(3): 977-85[DOI]
  • 19. Besbes S, Blecker C, Deroanne C, Drira NE, Attia H. Date seeds: chemical composition and characteristic profiles of the lipid fraction. Food Chem. 2004; 84(4): 577-84[DOI]
  • 20. Nguyen SD, Sok DE. Oxidative inactivation of paraoxonase1, an antioxidant protein and its effect on antioxidant action. Free Radic Res. 2003; 37(12): 1319-30
  • 21. Ng CJ, Shih DM, Hama SY, Villa N, Navab M, Reddy ST. The paraoxonase gene family and atherosclerosis. Free Radic Biol Med. 2005; 38(2): 153-63[DOI][PubMed]
  • 22. Mirdamadi HZ, Sztanek F, Derdak Z, Seres I, Harangi M, Paragh G. The human paraoxonase-1 phenotype modifies the effect of statins on paraoxonase activity and lipid parameters. Br J Clin Pharmacol. 2008; 66(3): 366-74[DOI][PubMed]
  • 23. Kassai A, Illyes L, Mirdamadi HZ, Seres I, Kalmar T, Audikovszky M, et al. The effect of atorvastatin therapy on lecithin:cholesterol acyltransferase, cholesteryl ester transfer protein and the antioxidant paraoxonase. Clin Biochem. 2007; 40(1-2): 1-5[DOI][PubMed]
  • 24. Dullaart RP, de Vries R, Voorbij HA, Sluiter WJ, van Tol A. Serum paraoxonase-I activity is unaffected by short-term administration of simvastatin, bezafibrate, and their combination in type 2 diabetes mellitus. Eur J Clin Invest. 2009; 39(3): 200-3[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments